SCHEMBL28889238

SCHEMBL28889238

CCNC(=S)NC(=O)C(c1cc(C(F)(F)F)ccn1)c1cccnc1OC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.37
P2RY1 P47900 6/20 0.37
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
ALOX12 P18054 1/20 0.35
RAF1 P04049 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29893632 1.00 ADRB2 (0.37) ADRB2P2RY1NPSR1ALDH1A1L3MBTL1
SCHEMBL28889277 0.91 P2RY1 (0.38) ADRB2P2RY1ALDH1A1L3MBTL1GAA
SCHEMBL29893566 0.88 ADRB2 (0.39) ADRB2NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL28889291 0.88 ADRB2 (0.39) ADRB2NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL28889349 0.85 P2RY1 (0.41) ADRB2P2RY1ALDH1A1L3MBTL1MEN1
SCHEMBL28889200 0.84 ADRB2 (0.41) ADRB2NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL28889381 0.80 ADRB2 (0.39) ADRB2P2RY1ALDH1A1L3MBTL1
SCHEMBL29893596 0.80 ADRB2 (0.39) ADRB2NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL28889374 0.80 ADRB2 (0.39) ADRB2NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL28889233 0.78 PHGDH (0.41) ADRB2NPSR1ALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215862-A Pyrimidone compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-21 CN disclosed